Wu AH - Search Results

1

Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure.

Wu AH, Smith A. Wu AH, et al. Eur J Heart Fail. 2004 Mar 15;6(3):355-8. doi: 10.1016/j.ejheart.2003.12.011. Eur J Heart Fail. 2004. PMID: 14987588 Free article. Review.

2

Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure.

Wu AH, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G. Wu AH, et al. Am J Cardiol. 2003 Sep 1;92(5):628-31. doi: 10.1016/s0002-9149(03)00741-0. Am J Cardiol. 2003. PMID: 12943894

3

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study.

Wu AH, Packer M, Smith A, Bijou R, Fink D, Mair J, Wallentin L, Johnston N, Feldcamp CS, Haverstick DM, Ahnadi CE, Grant A, Despres N, Bluestein B, Ghani F. Wu AH, et al. Clin Chem. 2004 May;50(5):867-73. doi: 10.1373/clinchem.2003.026138. Epub 2004 Mar 9. Clin Chem. 2004. PMID: 15010423

4

Optimum blood collection intervals for B-type natriuretic peptide testing in patients with heart failure.

Wu AH, Smith A, Apple FS. Wu AH, et al. Am J Cardiol. 2004 Jun 15;93(12):1562-3. doi: 10.1016/j.amjcard.2004.02.072. Am J Cardiol. 2004. PMID: 15194039

5

Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure.

Tang WH, Philip K, Hazen SL, Stevenson CE, Pepoy M, Neale S, Francis GS, Van Lente F, Smith A, Wu AH. Tang WH, et al. Among authors: wu ah. Clin Cornerstone. 2005;7 Suppl 1:S18-24. doi: 10.1016/s1098-3597(05)80010-9. Clin Cornerstone. 2005. PMID: 15899365

6

Reduced readmission rate for alternating diagnoses of heart failure and pulmonary disease after implementation of B-type natriuretic peptide testing.

Wu AH, Harrison A, Maisel AS. Wu AH, et al. Eur J Heart Fail. 2004 Mar 15;6(3):309-12. doi: 10.1016/j.ejheart.2003.12.014. Eur J Heart Fail. 2004. PMID: 14987581 Free article.

7

Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.

Wu AH, Smith A, Christenson RH, Murakami MM, Apple FS. Wu AH, et al. Clin Chim Acta. 2004 Aug 16;346(2):211-9. doi: 10.1016/j.cccn.2004.03.036. Clin Chim Acta. 2004. PMID: 15256323

8

Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle homeostasis.

Ruaño G, Thompson PD, Windemuth A, Smith A, Kocherla M, Holford TR, Seip R, Wu AH. Ruaño G, et al. Among authors: wu ah. Pharmacogenomics. 2005 Dec;6(8):865-72. doi: 10.2217/14622416.6.8.865. Pharmacogenomics. 2005. PMID: 16296949

9

Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.

Lee-Lewandrowski E, Januzzi JL, Green SM, Tannous B, Wu AH, Smith A, Wong A, Murakami MM, Kaczmarek J, Apple FS, Miller WL, Hartman K, Jaffe AS. Lee-Lewandrowski E, et al. Among authors: wu ah. Clin Chim Acta. 2007 Nov-Dec;386(1-2):20-4. doi: 10.1016/j.cca.2007.07.015. Epub 2007 Jul 25. Clin Chim Acta. 2007. PMID: 17854790

10

Interpretation of creatine kinase and aldolase for statin-induced myopathy: Reliance on serial testing based on biological variation.

Wu AH, Smith A, Wians F. Wu AH, et al. Clin Chim Acta. 2009 Jan;399(1-2):109-11. doi: 10.1016/j.cca.2008.09.023. Epub 2008 Sep 26. Clin Chim Acta. 2009. PMID: 18848535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,125 results

Search Page